YAZISIZ, V. Et Al. 2020. Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment. ARCHIVES OF RHEUMATOLOGY , vol.35, no.2 , 300-302.

YAZISIZ, V., UÇAR, İ., ASLAN, B., ERBASAN, F., & TERZİOĞLU, M. E., (2020). Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment. ARCHIVES OF RHEUMATOLOGY , vol.35, no.2, 300-302.

YAZISIZ, VELİ Et Al. "Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment," ARCHIVES OF RHEUMATOLOGY , vol.35, no.2, 300-302, 2020

YAZISIZ, VELİ Et Al. "Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment." ARCHIVES OF RHEUMATOLOGY , vol.35, no.2, pp.300-302, 2020

YAZISIZ, V. Et Al. (2020) . "Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment." ARCHIVES OF RHEUMATOLOGY , vol.35, no.2, pp.300-302.

@article{article, author={VELİ YAZISIZ Et Al. }, title={Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment}, journal={ARCHIVES OF RHEUMATOLOGY}, year=2020, pages={300-302} }